Adaptive Biotechnologies signed pharma deals with Biogen Idec for the study of the immune repertoire and the search for immunological biomarkers in difficult to treat autoimmune diseases. Read the full story

Big pharma company, AstraZeneca, has signed a deal to become pharma partners with Oxford Cancer Biomarkers to develop and personalize a cancer drug. Read the full story

The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Read the full story

Foundation Medicine announced the initiation of a strategic collaboration with Sanofi.

Foundation Medicine will use their genomic sequencing and analytic capabilities to identify genetic biomarkers and potential companion diagnostics for select Sanofi oncology drug candidates.  Read the full story

Research agreement with Pfizer for the identification of new Alzheimer’s disease (AD) biomarkers using Exonhit’s Genome-Wide SpliceArray™ (GWSA) platform.  Read the full story

GNS Healthcare has announced it has entered into a collaboration with Bristol-Myers Squibb focused on the discovery of novel disease biology and biomarkers in the area of immuno-inflammation. Read the full story

Evotec and Roche have announced a collaboration in novel protein-activity based biomarkers for Roche's oncology drugs under development. Read the full story